Skip to content
  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
  • —
  • Sign in

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

Your cart

  • Home
  • Catalog
  • About/Leadership
  • Press
  • Contact
FUNanc1al
0

Insider Purchases: Inside the Buy

Tag: AbbottLaboratories

Illustration depicting Abbott Laboratories as a futuristic healthcare city with FreeStyle Libre glucose sensors, cancer diagnostics trains labeled Cologuard and Cancerguard, happy doctors and patients, and a giant Dividend King castle.

June 24, 2026

🩺 Abbott Laboratories (ABT) Stock Analysis: Can a Dividend King Turn Exact Sciences Into Its Next Growth Engine?

Abbott Laboratories may not be flashy, but the healthcare giant combines insider buying, a growing oncology diagnostics platform, the dominant FreeStyle Libre franchise, and more than a century of dividend payments. With shares trading near 16x forward earnings, investors may be looking at a classic Growth at a Reasonable Price opportunity.

Read entire article

Tags: Abbott Laboratories, Abbott stock analysis, AbbottLaboratories, ABT, ABT stock, buy or sell ABT, cancer diagnostics, Cologuard, diagnostics stocks, dividend growth investing, Dividend King stocks, DividendKings, Exact Sciences acquisition, ExactSciences, featured-insiders, Frédéric Marsanne, FreeStyle Libre, FreeStyleLibre, FUNanc1al, GARP investing, healthcare innovation, healthcare stocks, hub-insiders, insider buying, InsiderBuying, medical devices, MedicalDevices, oncology investing, PhilipBoudreau, risks buying ABT, value investing, ValueInvesting, why buy ABT

Quick links

Search
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service

Contact us

@funanc1al
customer_service@funanc1al.com

About us

FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.

Follow us

Twitter
Instagram
TikTok
Linkedin
Youtube
Tumblr

© Copyright 2026 FUNanc1al
Powered by Shopify